ORIGINAL ARTICLE
Year : 2017 | Volume
: 30 | Issue : 4 | Page : 1168--1177
Predictive significance of stromal-associated lymphocytes in response to neoadjuvant chemotherapy in breast cancer
Afaf T Ibrahiem1, Hala A Mouhamed2, Abeer H Anter3 1 Department of Pathology, Faculty of Medicine, Mansoura University, Mansoura, Egypt 2 Department of Pathology, Faculty of Medicine, Suez Canal University, Ismailia, Egypt 3 Department of Clinical Oncology and Nuclear Medicine, Faculty of Medicine, Mansoura University, Mansoura, Egypt
Correspondence Address:
Afaf T Ibrahiem Department of Pathology, Faculty of Medicine, Mansoura University, Mansoura Egypt
Objective
In this work, we aimed to assess whether the high stromal-associated lymphocytes and their subtypes in pretreatment core biopsies from patients with invasive breast carcinoma have a predictive role in pathologic response to neoadjuvant chemotherapy (NACT).
Background
Tumor-infiltrating lymphocytes including stromal-associated lymphocytes in breast cancer are considered a form of the host immune response to malignancy. Several studies suggested that tumor-infiltrating lymphocytes could predict better response to NACT, but their roles in predicting complete pathologic response (pCR) rate after NACT still needs further evaluation.
Patients and methods
Stromal-associated lymphocytes were evaluated in 100 pretreatment core biopsies from primary breast cancer patients eligible for NACT. Cases were defined as lymphocyte-rich if the percentage of lymphocytes was more than 50% and also the lymphocytes were evaluated for CD20, CD3, CD8, and CD4. Type of pathological response to NACT was determined in post-therapy surgical specimens of the same patients, and we correlated between type of response to stromal-associated lymphocytes and their subtypes.
Results
pCR was detected in 22 (22%) breast cancer patients, partial pathologic response in 54 (54%), and no pathologic response in 24 (24%) patients. There was a significant association between percentage of stromal-associated lymphocytes and achievement of pCR rate (P = 0.006). In addition, high stromal-associated lymphocytes are significantly associated with advanced histological grade (P = 0.004), Ki-67 (P = 0.028), and negative estrogen receptor state (P = 0.015).
Conclusion
High stromal-associated lymphocytes and high percentage of CD8-positive T cells in stromal-associated lymphocytes could be reliable predictors for pCR rate after NACT.
How to cite this article:
Ibrahiem AT, Mouhamed HA, Anter AH. Predictive significance of stromal-associated lymphocytes in response to neoadjuvant chemotherapy in breast cancer.Menoufia Med J 2017;30:1168-1177
|
How to cite this URL:
Ibrahiem AT, Mouhamed HA, Anter AH. Predictive significance of stromal-associated lymphocytes in response to neoadjuvant chemotherapy in breast cancer. Menoufia Med J [serial online] 2017 [cited 2024 Mar 29 ];30:1168-1177
Available from: http://www.mmj.eg.net/article.asp?issn=1110-2098;year=2017;volume=30;issue=4;spage=1168;epage=1177;aulast=Ibrahiem;type=0 |
|
|